Rxwire
Trials & R&D · first seen yesterday, updated yesterday

Cellares pens 2nd automation test with Asia-based cell therapy partner in 2 weeks

Despite hitting a speed bump over the summer, automated cell therapy manufacturing specialist Cellares has continued to sign new partners at a steady pace, now inking a second agreement with an Asia-based organization in just over a week.

Summary from Fierce Pharma - Manufacturing.

Coverage 1 article · 1 outlet

  1. Fierce Pharma - Manufacturing
    Cellares pens 2nd automation test with Asia-based cell therapy partner in 2 weeks